Atlas Trials

Immunoregulatory Therapy for 2019-nCoV

Clinical trial NCT04268537 · UNKNOWN

Trial details

NCT number
NCT04268537
Sponsor
Southeast University, China
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
2019 nCoV, PD-1
Start date
2020-02-10
Primary completion
2020-04-30
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.